Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)

Annals of Oncology

Volumn 12, Issue 9, 2001, Pages 1231-1238

  Skarlos, D V ^a   Samantas, E ^b   Briassoulis, E ^c   Panoussaki, E ^b   Pavlidis, N ^c   Kalofonos, H P ^d   Kardamakis, D ^d   Tsiakopoulos, E ^e   Kosmidis, P ^f   Tsavdaridis, D ^g   Tzitzikas, J ^h   Tsekeris, P ^c   Kouvatseas, G ⁱ   Zamboglou, N ^j   Fountzilas, G ^h  

^a ATHENS MEDICAL CENTER   (Greece)

^b St Anargiri Cancer Hospital   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

^d UNIVERSITY OF PATRAS   (Greece)

^e NIMTS HOSPITAL   (Greece)

^f HYGEIA HOSPITAL   (Greece)

^g IKA Hospital   (Greece)

^h ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

ⁱ Hellenic Cooperative Oncology Group   (Greece)

^j Klinikum Offenbach GmbH   (Germany)

more..

Author keywords

Carboplatin; Etoposide; Limited disease; Small cell lung cancer; Thoracic radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; ETOPOSIDE;

ADULT; AGED; ANEMIA; AREA UNDER THE CURVE; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DEATH; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INFUSION; ESOPHAGUS DISEASE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GREECE; HEALTH STATUS; HEMATOLOGY; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; KIDNEY FUNCTION; LEUKOPENIA; LIVER FUNCTION; LUNG DISEASE; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PLEURA EFFUSION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SKULL IRRADIATION; THORAX; THROMBOCYTOPENIA; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DOSE FRACTIONATION; ETOPOSIDE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUTROPENIA; SURVIVAL ANALYSIS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 20244365160     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012295131640     Document Type: Article

References (30)

1. Therapy of small cell lung cancer. A perspective on two decades of clinical research
2. Chemotherapy with or without 3. Radiation therapy in limited small-cell carcinoma of the lung
3. VP-16 and cisplatin as first line therapy for small-cell cancer
4. Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and effective brain irradiation: A preliminary report
5. Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Cooperative Oncology study
6. A meta-analysis of thoracic radiotherapy for small-cell lung cancer
7. Rationale for different chemotherapeutic and radiation therapy strategies in cancer management
8. In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants
9. Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: A pilot study of the Eastern Cooperative Oncology Group
10. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide
11. Initial versus accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: A randomized study
12. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer
13. A multiple testing procedure for clinical trials
14. A network algorithm for performing Fisher's exact test in rxc contigency tables
15. Exact significance testing to establish treatment equivalence for ordered categorical data
16. Non parametric estimation from incomplete observations
17. Asymptotically efficient rank invariant test procedures (with discussion)
18. Regression models and little tables (with discussion)
19. Improving the quality of reporting of randomized controlled trials
20. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer
21. Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma
22. Phase III study of concurrent versus sequential thoracic radiotherapy (TRT) in combination with cisplatin (C) and etoposide (T) for limited stage (LS) small cell lung cancer (SCLC)
23. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung
24. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small cell lung cancer
25. Phase II trial of up-front accelerated thoracic radiotherapy combined with chemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer
26. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small cell lung cancer: The Japan Clinical Oncology Group study
27. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission